$0.5200
-0.07-11.86%
At close: -
$0.6700
0.1528.85%
After Hours: 7:59 PM EDT
Comments
Loading...
TransCode Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RNAZ | Benzinga
TransCode Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 8
EPS Estimate
$-3.210
Quarterly Revenue Estimate
$300.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of TransCode Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RNAZ | TransCode Therapeutics | -$21.45 | — | — | — | $0.00 | — | — | — | 05/14/2025 | Get Alert |
| RNAZ | TransCode Therapeutics | -$30.69 | -$3.21 | — | — | $0.00 | $300.00K | — | — | 04/08/2025 | Get Alert |
| RNAZ | TransCode Therapeutics | -$1.60K | -$16.17 | -$5.28 | 67.35% | $0.00 | $300.00K | $0.00 | -100.00% | 11/14/2024 | Get Alert |
| RNAZ | TransCode Therapeutics | -$4.34K | -$19.14 | -$24.42 | -27.59% | $0.00 | — | $0.00 | — | 08/14/2024 | Get Alert |
| RNAZ | TransCode Therapeutics | -$8.55K | -$16.50 | -$21.45 | -30.00% | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
| RNAZ | TransCode Therapeutics | -$10.30K | -$356.40 | -$30.69 | 91.39% | $0.00 | — | $0.00 | — | 04/01/2024 | Get Alert |
| RNAZ | TransCode Therapeutics | -$8.71K | -$1.44K | -$2.22K | -54.13% | $0.00 | — | $0.00 | — | 11/14/2023 | Get Alert |
| RNAZ | TransCode Therapeutics | -$9.50K | -$4.47K | -$4.34K | 2.95% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| RNAZ | TransCode Therapeutics | -$7.13K | -$4.47K | -$8.71K | -94.69% | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
| RNAZ | TransCode Therapeutics | -$6.07K | -$10.03K | -$10.30K | -2.63% | $0.00 | — | $0.00 | — | 03/31/2023 | Get Alert |
| RNAZ | TransCode Therapeutics | -$5.28K | — | -$8.71K | — | $0.00 | — | $0.00 | — | 11/14/2022 | Get Alert |
| RNAZ | TransCode Therapeutics | $13.46K | — | -$9.50K | — | $0.00 | — | $0.00 | — | 08/15/2022 | Get Alert |
| RNAZ | TransCode Therapeutics | -$25.61K | — | -$7.13K | — | $0.00 | — | $0.00 | — | 05/16/2022 | Get Alert |
| RNAZ | TransCode Therapeutics | -$4.75K | — | -$6.07K | — | $0.00 | — | $0.00 | — | 03/31/2022 | Get Alert |
| RNAZ | TransCode Therapeutics | -$7.92K | — | -$5.28K | — | $0.00 | — | $0.00 | — | 11/15/2021 | Get Alert |
| RNAZ | TransCode Therapeutics | — | — | $13.46K | — | — | — | $0.00 | — | 08/23/2021 | Get Alert |
TransCode Therapeutics (RNAZ) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-5.28 | $-16.17 | 67.3 % |
| Q2 | 2024-08-14 | $-24.42 | $-19.14 | -27.6 % |
| Q1 | 2024-05-15 | $-21.45 | $-16.50 | -30.0 % |
| Q4 | 2024-04-01 | $-30.69 | $-356.40 | 91.4 % |
TransCode Therapeutics (RNAZ) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $0 | $300.00K | -100.0 % |
FAQ
When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?
TransCode Therapeutics (RNAZ) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for TransCode Therapeutics (NASDAQ:RNAZ)?
The Actual EPS was $-5.28, which beat the estimate of $-16.17.
What were TransCode Therapeutics’s (NASDAQ:RNAZ) revenues?
The Actual Revenue was $0K, which missed the estimate of $300K.
Browse earnings estimates, EPS, and revenue on all stocks.